Wegovy® Consultation
$129.00
Begin your Wegovy® journey with a Wellcore provider consultation. If prescribed, your medication will be shipped through NovoCare—clinically proven to support appetite control and long-term weight management.
Use the chart below as a general reference for eligibility:
BMI ≤ 24.9: Not eligible
BMI 25.0–26.9: Case-by-case**
BMI 27.0–29.9: Likely eligible**
BMI 30.0+: Likely eligible**
*Your provider will determine final eligibility after reviewing your full health history.
**Eligibility may increase with weight-related health factors such as insulin resistance, prediabetes, or PCOS.
This FDA-approved treatment offers unique advantages:
- Mimics your body’s natural GLP-1 hormone to reduce appetite, cravings, and caloric intake
- FDA-approved specifically for chronic weight management in adults
- Shown to help patients lose 15% or more of their body weight over time
- Once-weekly, self-administered injection at home—no clinic visits required
- Licensed-provider-guided dosing, clinical oversight, and ongoing support
Simple administration details:
- Wegovy is injected once per week just under the skin (subcutaneous injection)
- Most patients begin with a low starter dose and gradually increase over 16–20 weeks to minimize side effects and optimize results
- Approved injection sites include the abdomen, thigh, or upper arm
- Your Wellcore care team will guide you through every step
Complete support package:
- Prescription for Wegovy (if clinically appropriate)
- Personalized dosing and titration schedule
- Access to licensed providers and Wellcore’s clinical support team
- Free insurance check available upon request
- Convenient, discreet home delivery of your medication
- Ongoing clinical oversight to optimize your results
Your Treatment Journey
Start Your Online Evaluation
Get approved by provider
Receive Your product at Home
Start treatment with provider guidance
What is Wegovy and how does it work?
Wegovy is an FDA-approved GLP-1 medication containing semaglutide. It mimics your body’s natural GLP-1 hormone to reduce appetite, regulate food intake, and support long-term weight management when combined with healthy lifestyle changes.
Who is eligible for Wegovy treatment?
You may be eligible if your BMI is 30 or higher, or 27+ with a weight-related condition like high blood pressure, insulin resistance, or PCOS. Final eligibility is determined after a clinical review by a Wellcore provider.
What kind of results can I expect with Wegovy?
Clinical studies show that patients may lose 15% or more of their body weight over time with consistent use, combined with a reduced-calorie diet and increased activity. Results vary, but most patients see gradual, meaningful progress over several months.
How is Wegovy taken?
Wegovy is a once-weekly injection administered just under the skin (abdomen, thigh, or upper arm). Most patients start at a low dose and gradually increase over several weeks to minimize side effects and support optimal outcomes.
What are the common side effects of Wegovy?
Temporary side effects may include nausea, constipation, diarrhea, headache, or fatigue—especially during the dose escalation phase. These often improve as your body adjusts, and your provider can offer tips to manage them.
Can I use Wegovy with other weight loss medications?
No. Wegovy should not be combined with other GLP-1 medications or products containing semaglutide. Always inform your provider about any medications or supplements you’re taking so they can ensure safe, effective care.
Important Safety Information
Wegovy contains semaglutide, a GLP-1 receptor agonist that helps regulate appetite and food intake. It should not be used with other GLP-1 medications or products containing semaglutide.
- Nausea, vomiting, or diarrhea
- Constipation or abdominal pain
- Indigestion (dyspepsia) or bloating
- Headache
- Fatigue
- Dizziness
- Belching or flatulence
- Gastroesophageal reflux disease (GERD)
- Gastroenteritis (stomach infection)
- Low blood sugar (especially in people with type 2 diabetes)
These side effects are often temporary and may improve as your body adjusts to treatment. To reduce nausea, your provider may recommend a gradual dose escalation plan.
- Do not use Wegovy if you are allergic to semaglutide or any of its ingredients
- Do not use Wegovy if you are pregnant, plan to become pregnant, or are breastfeeding
- Do not use Wegovy if you or a family member has ever had medullary thyroid carcinoma (MTC) or a condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Treatment Transparency
Wegovy (semaglutide) is an FDA-approved prescription medication for adults with obesity (BMI ≥30) or overweight (BMI ≥27 with a weight-related medical condition). All prescriptions are issued after a thorough review by a licensed provider. Medication is dispensed through FDA-registered pharmacies and shipped securely. Availability may vary by state and insurance coverage may impact cost.